| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |